| abstract |
The present invention provides the following formula (I): Or a pharmaceutically acceptable salt, hydrate or N-oxide thereof, and for the treatment of diseases which depend at least in part on binding to CXCR7 and CXCR7 activity Useful for. The invention thus relates, according to a further aspect, to a composition comprising said compound and a pharmaceutically acceptable excipient. |